Anti-Human RPL22 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22503; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human RPL22 Polyclonal Antibody: A Powerful Tool for Studying Protein Synthesis
The Anti-Human RPL22 Polyclonal Antibody is a highly specific and sensitive tool for studying protein synthesis in human cells. This antibody is produced using high-quality recombinant technology and has been rigorously tested to ensure its effectiveness in various experimental applications.
RPL22, also known as ribosomal protein L22, is a key component of the ribosome, the cellular machinery responsible for protein synthesis. RPL22 plays a crucial role in the assembly and stability of the ribosome, as well as in the translation of genetic information into proteins. As such, it is an essential protein for cell growth and survival.
The Anti-Human RPL22 Polyclonal Antibody is specifically designed for use in a variety of applications, including Western blotting, immunofluorescence, and immunohistochemistry. It has been validated for use in human tissues and cell lines, making it a versatile tool for researchers studying protein synthesis in different cell types.
This antibody has been successfully used in various experimental settings, including:
1. Detection of RPL22 protein levels in different cell lines and tissues.
2. Investigation of RPL22 expression in response to different stimuli or treatments.
3. Analysis of RPL22 localization and interaction with other proteins within the ribosome.
4. Evaluation of RPL22’s role in protein synthesis and its impact on cellular processes.
The Anti-Human RPL22 Polyclonal Antibody is a powerful and reliable tool for studying protein synthesis in human cells. With its high specificity and sensitivity, it enables researchers to accurately detect and analyze RPL22 protein levels and function. This antibody is an essential addition to any biotech lab studying protein synthesis and its role in cellular processes.
ProteoGenix catalogue number ARO-A22503. For research use only.
Target: Large ribosomal subunit protein eL22, 60S ribosomal protein L22, EBER-associated protein, EAP, Epstein-Barr virus small RNA-associated protein, Heparin-binding protein HBp15, RPL22; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
